Login to Your Account



Newron Raises CHF118.12M In Swiss Initial Public Offering

By Cormac Sheridan


Wednesday, December 13, 2006
Shares in Newron Pharmaceuticals SpA opened on the Swiss Stock Exchange in Zurich at CHF58 (US$48.20) Tuesday, more than 5 percent above its initial public offering price of CHF55 per share. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription